CNS Pharmaceuticals, Inc.

NASDAQ:CNSP

1.14 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Operating Activities:
Net Income -14.858-18.851-15.274-14.037-9.458-3.877-7.392-0.219
Depreciation & Amortization 0.0030.0040.0120.0130.0110.00200
Deferred Income Tax 000-0.7150000
Stock Based Compensation 0.8391.0071.2031.7241.2930.4770.110.12
Change In Working Capital -3.6943.6993.164-1.2390.834-0.4260.0840.047
Accounts Receivables 00000000
Inventory 00000000
Accounts Payables -3.6341.3221.70.5760.6570.1540.0710.057
Other Working Capital -0.062.3771.464-1.8150.177-0.5790.012-0.01
Other Non Cash Items 0.59600.3370.7150.0020.276.4810.002
Operating Cash Flow -17.113-14.14-10.558-13.538-7.318-3.553-0.716-0.112
Investing Activities:
Investments In Property Plant And Equipment -0.004-0.004-0.004-0.006-0.018-0.0200
Acquisitions Net 00000000
Purchases Of Investments 00000000
Sales Maturities Of Investments 00000000
Other Investing Activites 00000000
Investing Cash Flow -0.004-0.004-0.004-0.006-0.018-0.0200
Financing Activities:
Debt Repayment -0.301-0.43900-0.043-0.0350.30
Common Stock Issued 23.3762.31816.0384.65414.22210.2950.3910.101
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities -0.0452.75815.6134.509-0.04500.8610.223
Financing Cash Flow 23.034.63715.6134.50914.13410.261.1610.223
Other Information:
Effect Of Forex Changes On Cash 00000000
Net Change In Cash 5.913-9.5075.051-9.0356.7986.6860.4450.111
Cash At End Of Period 6.4610.54910.0555.00514.0397.2410.5550.111